Evogene Ltd. Reports Third Quarter 2013 Financial Results
Evogene Ltd. (TASE: EVGN), a plant genomics company specializing in enhancing crop productivity for the food, feed and biofuel industries, today announced its financial results for the third quarter and nine months ended September 30, 2013.
Ofer Haviv, Evogene's President and CEO, stated: “Last year, in view of the broad applicability of the unique technological capabilities and infrastructure that we have established over the past decade, we reorganized our company into four operating divisions, each focused on leveraging these assets to create improved products in a different and substantial market area.”
Help employers find you! Check out all the jobs and post your resume.